Optimizing oral antithrombotic therapy in patients post percutaneous coronary intervention
10.3969/j.issn.1004-8812.2025.11.001
- VernacularTitle:经皮冠状动脉介入治疗术后口服抗栓策略优化专家共识
- Author:
Jun-bo GE
;
Yong HUO
- Collective Name:National Clinical Research Center for Interventional Medicine,Expert Consensus on Optimizing Oral Antithrombotic Strategies Post Percutaneous Coronary Intervention
- Publication Type:Journal Article
- Keywords:
Percutaneous coronary intervention;
Antiplatelet therapy;
Oral anticoagulants
- From:
Chinese Journal of Interventional Cardiology
2025;33(11):601-613
- CountryChina
- Language:Chinese
-
Abstract:
Oral anti-thrombotic medication management is crucial for patients post percutaneous coronary intervention(PCI).Identifying the optimal balance between ischemic and hemorrhagic risks has consistently been a highly concerning and urgent issue for clinicians.Given individual variations in risk and drug responses,guideline-recommended strategies may not suit all patients.Recent studies have explored tailored anti-thrombotic strategies for diverse groups,providing evidence for guideline revisions and offering multiple clinical treatment options.However,patient assessment,adjustment timing,and strategy formulation lack standardization and flexibility,necessitating professional consensus.This consensus statement,carefully crafted to meet clinical needs,emphasizes dynamic assessment and holistic management,prioritizing individual differences and patient adherence.It aims to offer practical,optimized anti-thrombotic regimens to improve patients' long-term outcomes.
